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The search for myeloma proteins with antihapten activity has shown that some- 
where between roughly 1 and 10%, in different  series, bind nitrophenyl ligands  (1-4). 
Though the binding is generally exceedingly  weak, the overall frequency is still  sur- 
prisingly high (5). The reasons  for the high frequency are not clear and a number of 
possibilities  have been considered.  One is that nitrophenyls are bound nonspecifically 
at hydrophobic sites on immunoglobulins  (6). Another is that an unidentified,  preva- 
lent immunogen that happens to cross-react with nitrophenyls causes selective enrich- 
ment of the corresponding  lymphocytes; neoplastic transformation of these cells could 
then result in myeloma tumors whose myeloma proteins bind various nitrophenyls (7). 
To help evaluate these possibilities  we have examined the binding of a variety of 
substances by protein 315, which has higher affinity for the 2,4-dinitrophenyl (DNP) 
group than any of the other myeloma proteins so far studied  (5). The results show that 
(a) nonspecific binding does not account for protein 315's high affinity for DNP, and 
(b) a vitamin K-like molecule, 2-methyl-1,4-naphthoquinone, also called vitamin Ks 
or menadione,  is bound specifically and with considerable  affinity at a site that prob- 
ably overlaps the one that binds DNP ligands. 
In order to extend the comparison of myeloma protein 315 with conventional 
antibodies,  we  also  determined  the  temperature  dependency  of  its  binding 
reactions  with  e-DNP-lysine  and  vitamin  Ka,  and  we  compared some of its 
binding properties with  those  of rabbit  and  guinea pig antibodies  raised  by 
ordinary immunization procedures  against  the  2,4-DNP,  the  2,6-DNP,  and 
the  2,4, 6-(TNP)  groups.  All of the  results emphasize the  similarity between 
the ligand-binding properties of myeloma protein 315  and  conventional  anti- 
nitrophenyl antibodies,  many of which  also exhibit the  "strange"  (i.e., unex- 
pected)  cross-reaction with vitamin K3. The recognition of this  cross-reaction 
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and some of the other results  described here were previously summarized  in  a 
symposium on  "Experimental Approaches  to  Homogeneous  Antibody Popula- 
tions"  (5). 
Materials and Methods 
MOPC-315.--This tumor was generously provided by Dr. Michael Potter, National Insti- 
tutes of Health, Bethesda, Md.; it was maintained by serial subcutaneous transplantation at 
about 3-wk intervals in BALB/c mice from Cumberland Farms, Tenn., for about  1 yr and 
then in BALBcAnN mice provided by Dr. Ralph J. Graft. Blood from tumor-bearing mice was 
drawn by cardiac puncture, and serum was stored at about -- 20°C. 
Protein 315.--The protein was isolated from serum by two methods  (2,  8).  In both the 
protein was recovered in its 7S form (S uncorr.  =  6.6),  had the same affinity for ~-DNP-L- 
lysine as previously reported (2), and gave a single precipitin band in immunoelectrophoresis 
with rabbit antiserum prepared against serum from BALB/c mice. 
Antibodies to Nitrophenfls.--Rabbit antibodies  to the 2,4-DNP  group were isolated  (9) 
from antisera obtained several weeks after a booster injection of 2,4-DNP-hemocyanin, given 
3 mo after an initial injection of the same antigen. Purified rabbit antibodies to the 2,4,6-TNP 
group and purified guinea pig antibodies to the 2,6-DNP group were generously provided by 
Dr.  J.  R.  Little. The anti-TNP  antibodies were obtained  after a  booster injection of the 
TNP-B~,G given 1 after primary immunization with the same antigen (10). The anti-2,6-DNP 
antibodies were isolated as described (11). 
Reagents.--2-[methyl-14C]-l,4-naphthoquinone  (menadione,  vitamin  Ks)  was  obtained 
from Nuclear-Chicago Corp., Des Plaines, Ill. (spec act given as 9.7 mCi/mmol); m.p. 103 °- 
I04°C. It was indistinguishable from unlabeled menadione when used as ligand in fluorescence- 
quenching titrations  (e.g.,  Fig. 2,  below). Nonradioactive menadione was crystallized from 
methanol (m.p. 105°C); its molar extinction coefficient in 0.15 M NaC1  -- 0.01 K phosphate, 
pH 7.5 (phosphate-saline) was 20,000 at 252 nm ()~max). 
2,4-Dinitronaphthol  (m.p.  138  °) had  a  molar extinction coefficient of 14,360 at 395  nm 
(;kmax) in phosphate-saline (0.15 M NaC1 -- 0.01 K phosphate, pH 7.4). 1,4-Naphthoquinone, 
p-benzoquinone, and methyl p-benzoquinone were purified by sublimation. When necessary, 
other ligands were recrystallized until melting points agreed with literature values. 
4-Mononitrophenyl  (MNP)-aminocaproate,  2,6-DNP  aminocaproate,  and  2,4,6-TNP 
aminocaproate were all generously donated by Dr. J.  R. Little (see ref.  11). ¢-2,4-DNP-L- 
lysine (DNP-lysine) was obtained from Sigma Chemical Co., St. Louis, Mo. [SH]-e-2,4-DNP- 
L-lysine was prepared as described (2). 
Equilibrium D/a/ys/s.--The binding of various ligands was evaluated from their inhibition 
of the binding of [3H]-¢-DNP-L-lysine by protein 315 in equilibrium dialysis. Kr, the intrinsic 
association constant for the inhibiting ligand, was determined from Karush's equation (12): 
Kz  =  (r/r'  --  1)(1  +  Kc)/I  (eq.  1) 
where r and r' refer, respectively, to moles [SH]-¢-DNP-L-lysine  bound per mole protein in the 
absence (r) and presence (r') of the inhibitor, whose free (unbound) concentration is I; the free 
concentration of the reference ligand ([SH]-¢-DNP-Ldysine)  is c. I  was taken as the total con- 
centration of inhibitor, which was added in large molar excess over the protein (at least 1,000- 
10,000-fold),  while ¢ was measured by counting SH in the protein-free compartment. Based on 
equilibrium dialysis in the absence of the inhibitor, K, the intrinsic association constant for 
e-DNP-L-lysine, was 1.2 X  l0 T  M- 1 (4oc), in agreement with a previous finding (2). 
All equilibrium dialysis measurements were carried out at 4°C (unless  specified  otherwise) 
in small lucite chambers with 0.1 ml of protein solution (containing inhibitors as indicated) 
separated by a Visldng membrane from 0.1 ml of buffer with [SH]-e-DNP-L-lysine (13). After MARIA C.  MICHAELIDES AND  HERMAN N.  EISEN  689 
standing 40-48 h (without agitation),  duplicate 25-#1 portions from each compartment were 
counted in 10 ml of Bray's solution in a Packard  scintillation counter  (Packard Instrument 
Co., Inc., Downers Grove, Ill.). 
Protein concentration was measured by absorbancy at 278 rim, using the extinction coeffi- 
cient (1.24 cm2/mg) and mol wt (150,000) determined previously (2, 14). Calibration  curves 
relating  r  and c (see above) were constructed  from equilibrium dialysis experiments with 
[3H]-¢-DNP-L-lysine  as the sole ligand; for a given value of c in the presence of an inhibitor the 
corresponding r' value was obtained for use in equation  1. The KI value determined in this 
manner  for menadione was confirmed by equilibrium dialysis with radiolabeled [t4C]menadione 
in the absence of E-DNP-L-lysine  (compare Fig. 1 and Table III). 
Fluorescence Quenching.--Binding was also evaluated by the method of fluorescence  quench- 
ing (15). The maximum quenching values (Qmax) used for calculation of intrinsic association 
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FIG.  1.  Binding of  [14C]menadione by myeloma protein  315. Equilibrium  dialysis was 
carried out with protein at 95 #g/ml. Each point is the average of duplicate determinations. 
Final concentrations of menadione ranged from 0.26 to 5.3 X 10- 6 M/L. The volume on either 
side of the membrane was 0.1 ml. PBS Buffer; 4°C. 
constants were: 69% for protein 315 (2), 75% for rabbit IgG anti-2,4-DNP (15), 55%  for 
rabbit IgG anti-2,4,6-TNP (10), and 90% for guinea pig anti-2,6-DNP (11). Absorption 
spectra and difference  absorption spectra were determined in a Cary spectrophotometer, model 
14, as described (16). 
RESULTS 
The possibility that DNP ligands are bound nonspecifically at hydrophobic 
sites  on  protein 315  was  tested  with  1,8-anilinonaphthalene sulfonate  (1,8- 
ANS; ref.  6). At 4  X  10  .4 M,  1,8-ANS reduced the binding of [3H]-E-DNP-L- 
lysine  (free  concentration, 2  k  10  -6  M)  by  less  than  10%  and  the  KI  for 
1,8-ANS  was  <2  X  102  M -1.  1,8-ANS  also  had  a  negligible effect  on  the 
binding of  ¢-DNP-lysine by  a  conventional preparation  of  purified  rabbit 
anti-DNP  antibodies,  whose  average  affinity  for  the  DNP  group  was  low 
(5.5  X  105 M -1 for  ¢-DNP-l.-lysine and Kx for  1,8-ANS  ca.  3  k  103  M-~). 690  CROSS-REACTIONS  OF  VITAMIN  K8  AND  DNP 
Further evidence for the specificity of the binding of ~-DNP-lysine by protein 
315  was  provided by competitive equilibrium  dialysis  with  ~-pipsyl-L-lysine 
and  ~-dansyl-L-lysine,  whose  Kx  values  (vs.  [SH]+DNP-L-lysine)  were  ca. 
5  X  los and ca. 7  X  los M -~, respectively, or about  1,000-fold less than the 
affinity for ~-DNP-L-lysine. 
A  number of purines,  pyrimidines,  and  nucleic acids  were  also  tested for 
ability to inhibit the binding of ~-DNP-L-lysine, because of the suggestion by 
Schubert et al (3) that some myeloma proteins that appear to have antinucleic 
acid activity also react (though weakly, ref. 5) with DNP groups. The results 
are  shown in Table I.  The KI values for 5-acetouracil caproate  and 5-iodo- 
orotic acid were  1-2  X  104 M -1,  or about  1,000-fold less  than for ~-DNP-L- 
lysine. The other nucleotides were bound much less (KI <  104 M-l),  and  no 
inhibition was detected with several nucleic acid preparations. 
The K~ values for some other substances are listed in Table II and III.  The 
binding of a 2,4-dinitrophenylazo dye is in accord with the known affinity for 
DNP ligands.  However, a  number of structurally unrelated substances  were 
also  bound  to  a  notable  extent  (tetrahydrofolate,  riboflavin,  flavin  mono- 
nucleotide in Table II); of these,  the most impressive binding was seen with 
menadione. The affinity of protein 315  for the latter was confirmed by equi- 
librium dialysis with  [~4C]menadione in  the  absence of a  competitive ligand: 
the intrinsic association constant was 5  X  l0  s M -1 (Fig. 1), in agreement with 
both the value obtained by fluorescence quenching (6 X  los M -1, Fig. 2) and 
the KI value in Table III (6 >(  los M-l). 
The number of combining sites for menadione on protein 315  appeared to 
be about 1.4/150,000 daltons (Fig. 1), and the same number of sites for ~-DNP- 
L-lysine was  found in  a  previous study  (2).  However, protein 315  has  since 
been shown to have close to 2.0 sites/150,000 daltons for both menadione and 
~-DNP-lysine, providing equilibrium dialysis is carried out at higher  protein 
concentrations than were used in the experiment of Fig.  1  (0.05 mg/ml),  or a 
protective protein, such as gelatin, is added (14). 
In view of the structural difference between the DNP group and menadione 
(see Fig. 5, below) a study was made of the binding of this naphthoquinone by 
antibodies to diverse nitrophenyls. As is shown in Fig. 2, rabbit anti-2, 4-DNP 
rabbit  anti-2,4,6-TNP,  and  guinea  pig  anti-2,6-DNP  also  had  substantial 
affinity for menadione. For purposes of comparison with menadione, the bind- 
ing of 2,4-dinitronaphthol by these antibodies and by protein 315 is also shown 
in  Fig.  2.  From  the  summary given in  Table IV it  is  clear that  315  bound 
menadione  better  than  2,4-dinitronaphthol,  whereas  the  rabbit  and  guinea 
pig  antinitrophenyls  bound  dinitronaphthol  more  strongly  than  menadione. 
As expected, the conventional antibodies were heterogeneous with  respect to 
affinity (a values much less  than  1.0), whereas the combining sites of protein 
315 appeared homogeneous (a values were close to 1.0). 
The specificity of protein  315  for menadione was  indicated  by  the  sharp MARIA C.  MICHAELIDES AND  HERMAN N.  EISEN  691 
TABLE I 
Binding of Some Purines, Pyrimidines, and Nucleic Acids by Protein 315 
Total (free) 
Inhibitors  inhibitor  I/c*  Inhibitions  K1 
concentration  (I) 
MIL(x io-')  %  LI~I(× io  -~) 
Purines 
Adenine  10.0 
Adenosine  2.0 
Adenylic acid  2.0 
Deoxyadenylic acid  2.0 
Gtmnosine 
Guanylic acid  2.0 
Deoxyguanylic acid  2.0 
Pyrimldines 
5-Acetouracil caproic acid  1.0 
5-Acetouracil  1.0 
Thymine  10~0 
Thymidine  1.0 
Deoxythymidylic acid  2.0 
Uracil  10.0 
Uridine  I0.0 
Urldylic acid  2.0 
5-Hydroxyuridine  10.0 
5-Nitrouracil  10.0 
Isoorotic  5.0 
5-Iodoorotic acid  1.0 
Cytidine  2.0 
Cytosine  2.0 
Cytidylic acid  2.0 
Deoxycytidylic acid  2.0 
Carboxymethylcytosine  10.0 
Nucleic Acids 
BALB/c mouse spleen DNA  50§ 
Salmon sperm DNA  50§ 
Yeast RNA  I.  0 
9,280  50  0.27 
1,570  30  0.53 
1,580  41  0.85 
1,690  36  0.66 
0.21 
1,780  23  0.34 
1,650  25  0.39 
83O 
1,180 
9,860 
1,120 
1,530 
12,500 
14,000 
1,830 
13,000 
9 770 
5840 
1  160 
1 830 
1 830 
1 890 
1 530 
10 370 
46  2.44 
10  0.26 
27  0.09 
I1  0.30 
27  0.46 
26  0.08 
18  0.05 
25  0.38 
21  0.06 
25  0.06 
18  0.10 
10  1.0S 
10  0.12 
12  0.15 
22  0.31 
28  0.48 
18  0.06 
1,300[[  N¶  <O.O2 
1,30011  N  <O.02 
570  N  <0.02 
* Ratio of inhibitor concentration  (I)  to concentration  of free [3H]-e-DNP-L-lysine (c). 
Inhibition  of [~H]-¢-DNP-L-lysine  binding  relative to its binding  in absence of inhibitor 
(see eq. 1). 
§ #g/ml. 
[[ Corresponds to about 1.6  ×  10  -4 M/L per nucleotide (avg. mol wt  =  300) or about 
1 X  10  -s M if 10 nucleotides are assumed to represent one antigenic determinant, i.e., at 
100-1,000-fold molar excess over DNP-L-lysine. 
¶ None detectable (<  10%). 
reduction in affinity for some analogues  (see  Fig. 5).  For example, phthiocol 
was hardly bound to a  detectable extent, and the K, value for 1,4-napthoqui- 
none was about one-tenth that of menadione (Table III). 
Subsets of conventional anti-2,4-DNP antibodies were previously found to 692  CROSS-REACTIONS OF VITAMIN K3 AND  DNP 
TABLE II 
Binding of Diverse Other Compounds  by Protein 315 
Total (free) 
Inhibitors  inhibitor  I/c*  Inhibition~  Kx 
concentration  (I) 
2,4-Dinitrophenylazo- 
1-naphthol-3,6-disulfonate 
Tetrahydrofolic  acid  2.0 
Pyridoxol  1.0 
Riboflavin  0.37 
Flavin mononucleotide  1.0 
Flavin adenine dinucleotide  1.0 
Nicotinamide  1.0 
Nicofinamide adenine dinucleotide  1.4 
Nicofinamide adenine dinucleofide  1.3 
phosphate 
Barbital  300.0 
Barbituric  acid  10.0 
Isobarbituric  acid  5.0 
Theophylline  10.0 
Caffeine  10.0 
Theobromine  50.0 
O-Nitrophenyl  galactose  10.0 
Lactose  100.0 
M-chlorocarbonyl cyanide  1.0 
phenylhydrazone 
Isophthalate (meta)  3.8 
M/L(X 10  -4)  %  L/~(X 10  -4) 
0.07  550  61  66.5 
1,300  68  5.8 
900  42  2.1 
300  41  3.7 
700  67  6.8 
1,000  38  1.5 
1,000  23  0.8 
1,700  17  0.3 
1,600  19  0.4 
33,000 
12 400 
5 800 
6000 
5000 
3 200 
1 200 
118 000 
1 200 
13  0.02 
18  0.05 
27  0.2 
82  1.6 
90  3.8 
65  1.3 
14  0.4 
19  0.006 
48  1.7 
5,100  N§  <0.02 
* Ratio of inhibitor concentration to concentration of free [3H]-e-DNP-L-lysine (c). 
:~ Inhibition of [3H]-e-DNP-L-lysine binding (see Table I footnote). 
§ None detectable  (< 10%). 
differ  markedly  in  reactivity  with  5-acetouracil  caproate,  another  strange 
cross-reaction  (3,  17).  As is shown in Table V, a  subset  with high affinity for 
5-acetouracil caproate had relatively high affinity for menadione, while another 
subset  had  much  lower  affinity  for  both  of  these  ligands;  the  subsets  were 
similar,  however,  in  their  affinities  for  ,-DNP-lysine  and  for  2,4-dinitro- 
naphthol. 
Because the binding of DNP and TNP ligands by conventional anti-DNP and 
anti-TNP  antibodies  is  characterized  by a  large decrease  in enthalpy  (10),  it 
was of interest to determine the effect of temperature on the binding of ~-DNP- 
L-lysine and of menadione by protein  315.  As is shown in Fig.  3,  the binding 
of both ligands by the myeloma protein was also markedly exothermal. 
In view of the  red shift  and hypochromic change undergone  by DNP  and 
TNP  ligands  in  the  combining sites  of protein  315  (2)  and  of conventional 
antibodies  (16), similar changes were sought with menadione. When bound by 
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TABLE III 
Binding of Menadione and Some Related Substances by Protein 315 
Total (free)  Inhibi- 
Inhibitor  inhibitor  I/c*  tion$  KI  Q'§ 
Concentration (I) 
~//L(X 10  -4)  %  L/~/(X 10-  ~) 
Menadione  1.0  480  95  52  30 
14(2 menadioneII  0.027  26  46  68 
1,4-Naphthoquinone  0.5  250  45  6  14 
1,4~Naphthoquinone 2 sulfonic  <5 
acid 
1,2-Naphthoquinone 4 sulfonic  0.1  113  15  4  <5 
acid 
Phthiocol (1,4-naphtho-  1.0  1,430  <10  <0.2 
quinone 2 methyl, 3 hydroxy) 
p-Benzoquinone  0.5  262  <10  <0.2  <5 
Methyl-p-benzoquinone 
Dicumarol  1.0  900  62  4  < 5 
2,4-Dinitron&phthol  0.21  107  20  12  10 
* Ratio of inhibitor concentration to concentration of free [3H]-~-DNP-L-lysine  (c). 
Inhibition of [3H]-e-DNP-L-lysine binding. 
§ Q' is percent quenching of protein fluorescence (290  nm activation, 345  nm emission) 
following addition of 2-4 nmol llgand (in the case of p-benzoquinone 13 nmol were used)  to 
0.42 nmol protein in a final vol of 1.2 ml. 
I[ Direct binding with this ligand yielded a K  (assoc.)  value of 5.1 X  105 M- 1 (Fig. 1). 
shift (340-350  nm) and a hypochromic change (22 %)  (Fig.  4). Hypochromia, 
but no  red shift,  was observed when menadione  was  bound by rabbit  anti- 
2,4-DNP  antibodies,  and  by tryptophan  at  high  concentration  (as  the  free 
amino acid). These changes are concordant with the similar  but more marked 
changes  observed when DNP  (and especially  TNP)  ligands  form  complexes 
with tryptophan  (free amino acid).  All of these changes in absorption spectra 
were more readily apparent in difference spectra (lower panels of Fig. 4 A, B, 
C).  With normal  rabbit 7-globulin as control there was no change in mena- 
dione's absorption spectrum. 
DISCUSSION 
Protein  315,  a  mouse IgA myeloma protein  with  considerable  affinity for 
DNP and TNP ligands,  was tested for ability to bind approximately 57 benze- 
noid, heterocyclic, and other substances. A number of purine and pyrimidine 
derivatives were bound weakly (< 1 X  105 L/M), but only menadione (vitamin 
K3) was bound with an affinity (5  X  105 L/M) that approximates the values 
commonly observed with benzenoid ligands  and their antibodies. Other ligands 
could have been overlooked because the assay, chosen for convenience,  detected 
only substances  whose binding  interfered  with  the  binding  of the  reference 
ligand ([3H]-  ~-DNP-L-lysine). 694  CROSS-REACTIONS  OF  VITAMIN  K3  AND  DNP 
:or\  oo 
,0  20 
nanomoles  added 
Fx6. 2.  Fluorescence quenching titrations of protein 315 and some antinitrophenyl anti- 
bodies with e-2,4-DNP-L-lysine (O), menadione (O), and 2,4-dinitronaphthol (O). In each 
titration a  total of 0.2 ml of ligand (1  X  10- 5 M/L) was added to 1.0 ml containing 50 #g 
purified antibody or myeloma protein. The final value at end of the titration is called Q' (see 
Tables III and V).  Temperature, 4°C. 
TABLE IV 
A~inity of MOPC-315 and Conventional A ntinitrophenyls for Menadione and 
2,4-Dinitronaphthol* 
Rabbit  Rabbit anti-  Guinea pig 
Ligands  Protein 315  anti-2,4-DNP  2,4,6-TNP:~  anti-2,6-DNP$ 
Menadione 
2,4-Dinitro- 
naphthol 
Ko-Menadione/ 
Ko-Dinitro- 
naphthol 
K(XIO  5  Ko(XIO  -5  Ko(XI~  5  Ko(XlO -5 
L/M)  a  ~M)  a  L/M)  a  L/M)  a 
5.6§  0.8  1.6  0.5  4.0  0.5  19  0.5 
1.11l  1.0  8.0  0.3  75  0.5  130  0.4 
5.0  0.2  0.05  0.2 
* Affinity values based on fluorescence quenching titrations in Fig. 2. K, intrinsic associa- 
tion constant; Ko, average intrinsic association constant; a, heterogeneity index for K values 
estimated from Sips plots (1.0 represents homogeneous sites; heterogeneity increases as values 
approach zero). Essentially the same values were given in a preliminary report (6). 
J; These purified antibodies were generously provided by Dr. J. R. Little. 
§ By equilibrium dialysis with [t4C]menadione K  =  5.1 X  105 L/M, Fig. 1. 
tl By competitive equilibrium dialysis KI =  1.2 X  105 L/M. Table III. 
Three  observations emphasize  that  menadione is  bound specifically,  rather 
than  nonspecifically  through  hydrophobic  bonds  at  an  apolar  patch  on  the 
surface  of  the  protein.  (a)  A  variety  of  other  relatively hydrophobic  ligands 
(dansyl, pipsyl,  1,8-anilinonapthalene sulfonate) are not bound to a  significant 
extent  by  protein  315  (2).  (b)  Analogs  of  menadione  with  small  structural MARIA C.  MICHAELIDES AND HERMAN N.  EISEN  695 
TABLE V 
A.ginities of Subsets of Guinea Pig Anti-2,4-DNP Antibodies for Menadione and other Ligands* 
Ligand 
Antibody  E-DNP-L-lysine  2,4-Dinltronaphthol  Menadione 
Q'  Ko  Q'  Ko  Q'  Ko 
Subset 15  69.7  ca. 2  X  l0 s  66.0  5  X  107  50.6  1.0  X  10 s 
Subset 2§  66.6  ca. 2  X  10 s  62.0  1  X  10  ~  34.2  1.3  X  106 
* Based on fluorescence  quenching  titrations, calculated on the basis of Qmax =  90. QJ is 
percent  quenching of  protein fluorescence  after addition of 1-4 nmol ligand to 0.35 nmol 
protein in a final vol of 1.2 ml (see  legend,  Table III). 
:~ This subset of purified anti-DNP was precipitated by 5-acetouracil-protein  and has a 
high affinity for 5-acetouracil  caproate (16). 
§ This subset of purified anti-DNP was not precipitable by 5-acetouracil-protein  and has 
barely measurable affinity for 5-acetouracil  caproate (16). 
modifications that hardly change the overall apolar character (phthiocol, with 
addition of an OH group at carbon 3, and 1,4-naphthoquinone, in which the 
CH3 at carbon 2 is deleted; see Fig.  5,  below) are bound much less well.  (c) 
The  binding  of  menadione  is  markedly  temperature-dependent  (enthalpy 
driven), whereas binding due simply to hydrophobic bonds is characteristically 
independent of temperature (19). 
The intrinsic  association constant for the reversible binding of menadione 
was the same when estimated in the presence or absence of DNP-lysine, show- 
ing that menadione binding is not due to "unmasking" a site by a conforma- 
tional  change induced  by  the  binding of  ~-DNP-lysine.  These findings  also 
suggest that the reduced binding of e-DNP-lysine in the presence of menadione 
is due to competitive blocking via steric hindrance rather than to a conforma- 
tional change in the site for DNP-lysine brought about by binding of mena- 
dione at a distant site. 
A  cross-reaction  between  structures  as  different as  DNP  and  menadione 
would hardly have been predicted from past experience with hapten binding 
by antibodies  (20,  21): hence it has been designated a  strange cross-reaction 
(5). However, examination of models shows that with superimposition of their 
benzene rings,  there can be considerable overlapping of DNP and menadione 
(Fig. 5). In addition, the molecules have similar charge distribution: electron- 
withdrawing oxygen atoms establish positively charged rings capable of serving 
as acceptors in  charge-transfer complexes. In view of these similarities  their 
cross-reaction seems not to be so strange after all. 
It  is  thus  not  surprising  that  the  DNP/menadione  cross-reaction is  also 
evident with  many antibodies  raised  by conventional procedures in  rabbits 
and  guinea  pigs  to  various  nitrophenyls  (anti-2,4-DNP;  anti-2,6-DNP, 
anti-2,4,6-TNP)  (Fig. 2). It also occurs (at lower affinities) with protein 460 
another mouse IgA myeloma protein with  anti-DNP  activity  (22,  23).  The 696  CROSS-REACTIONS  OF  VITAMIN  K~  AND  DNP 
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FIG. 3. Temperature dependency of binding ~-DNP-lysine and menadione by protein 315. 
K  values, the intrinsic association constants at various temperatures, were determined by 
fluorescence quenching (©) or equilibrium dialysis (D). AH, the enthalpy change on binding, 
was --13,500 and  --7,230 cals/mol ligand bound for e-DNP-lysine and menadione, respec- 
tively. 
gross  similarity  in  shift  of  absorption  spectrum  of menadione  and  of DNP 
when  bound  specifically  by  protein  315  and  by  antinitrophenyl  antibodies 
probably derives from the environment at the sites which these ligands occupy; 
they might reflect contact with  tryptophan residues with, perhaps, formation 
of  charge-transfer  complexes.  Several  tryptophans  in  the  V  regions  of  the 
protein's light  and heavy chains  are candidates  for such  complexes  (24,  25). 
Interactions with tryptophan have also been suggested as a possible basis for 
the  otherwise  unexplained  marked  changes  in  enthalpy  associated  with  the 
specific binding of DNP and of menadione to protein 315  and to conventional 
antibodies (26). 
It is possible that not all conventional anti-DNP molecules bind  menadione. 
Anti-DNP  subsets  that  were  separated  (17)  on  the  basis  of  their  ability  to 
engage in  another strange  cross-reaction,  with  5-acetouracil,  differed in  their 
reaction with menadione. The subset that reacted best with 5-acetouracil also 
reacted best with menadione and with dinitronapthol.  These results emphasize 
the  importance of antibody diversity for comparisons of the  combining sites MARIA  C.  MICHAELIDES  AND  HERMAN  N.  EISEN  697 
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FIo. 4.  Change in absorption spectrum of menadione when bound by protein 315, rabbit 
anti-2,4-DNP antibodies, and tryptophan  (as free amino acid). Spectra in the upper panels 
were determined vs. buffer. Difference spectra in lower panels were obtained in tandem cuvets 
with menadione plus appropriate protein (or tryptophan) in the one beam and free menadione 
and free protein in the reference beam (15). Hydrogen (O,  D, A) and tungsten (Q, I,  A) 
hmps gave the same results for free menadione (O, Q), bound menadione (D, I), and for the 
difference spectra  (A, A). Protein concentrations in mg/ml were: protein 315,  2.7; rabbit 
anti-DNP antibody, 4.4; nonspecific rabbit 3~-globulin (pseudoglobulin), 3.6; tryptophan con- 
centration was ca. 0.02 M/L. Total menadione concentration was 1.37 X  10-b  M/L, except 
for the curves without symbols in lower panels A and B where it was increased to 6 ×  10- 5 
M/L (symbols for H2 and tungsten lamps omitted for simplification). Difference spectra were 
obtained with a slide wire that gave full-scale pen deflection for an absorbancy of 0.100. PBS 
buffer; 14°C. 698  CROSS-REACTIONS OF  VITAMIN Ka  AND DNP 
FIo. 5.  Models of 2,4-dinitrophenyl  (I), with X representing an unspecified atom (C, N, or 
other), and of menadione (II). B refers to benzene rings, A to the quininoid moiety of mena- 
dione. In the lower photograph,  DNP is superimposed on the benzene ring of menadione and 
rotated 60  ° to maximize overlap. Phthiocol  (see text) is menadione with an OH on carbon 3; 
1,4-naphthaquinone  (see text)  is menadione without the CH3 on carbon 2 (the carbons are 
numbered clockwise with carbon 1, substituted  with 0, at the top of ring A). The models were 
kindly constructed  to scale by Mitchell Schwartz, using accepted bond angles and distances; 
hydrogen atoms are omitted. 
on a  given myeloma protein with  those in a  heterogeneous population of con- 
ventionally  raised  antibody  molecules.  For  example,  the  finding  by  Glaser 
and  Singer  (27)  of a  circular  dichroism  difference  between  the  specific  com- 
plexes  formed  by  ~-DNP-lysine  with  protein  315  and  with  conventionally 
induced mouse anti-DNP  antibodies  leaves open the possibility that  a  subset 
of the induced, heterogeneous antibody population could resemble protein 315 
in  this  property.  Karush  has observed  that  different  isoelectric-focusing frac- 
tions of antilactosyl antibodies from a single rabbit cause substantially different 
spectral shifts of bound azophenyl lactoside,  even when the fractions have the 
same affinity for this ligand (28). 
Because  of the  pronounced structural  difference  between  DNP  and mena- 
dione, the binding of both ligands by the same immunoglobulin has been taken 
as  support  for the  idea  that  individual  immunoglobulin  molecules  are multi- 
specific  (1,  29).  From  the  structural  overlap  revealed  by Fig.  5,  however,  it 
would seem  that  a  stronger  argument  for multispecificity  would be provided MARIA  C.  MICHAELIDES  AND  HERMAN  N.  EISEN  699 
by ligands  with so little structural  similarity  that  they would be more likely 
to bind to different, entirely nonoverlapping sites within the combining region 
(VT. and VH) of the same immunoglobulin.  One way to detect such honorer- 
lapping  ligands  for  a  protein  that  binds  DNP  and  menadione  would be to 
repeat  the screening exercise described in  this paper  with  [~4C]menadione  (in 
place  of  radiolabeled  DNP-lysine)  as  the  reference  ligand.  It  may  thus  be 
possible to identify a molecule  (call it X)  that  inhibits  the binding  of mena- 
dione  but  not  that  of DNP-lysine:  X  and  DNP-lysine  might  then  occupy 
entirely  separate  but  neighboring  sites  within  the  immunoglobulin's  com- 
bining region. 
In order  to be significant  biologically, multispecificity must involve stimu- 
lation of a  given lymphocyte by structurally  dissimilar immunogens,  not just 
binding  of different  ligands  by a  particular  Ig.  That  antibody-forming  cells 
can  be  stimulated  in  secondary  immune  responses  by similar  cross-reacting 
ligands (say, 2,4-DNP and 2,4,6-TNP) is strongly implied by the phenomenon 
of  "original  antigenic  sin"  (30-32);  and  recent  findings  of Varga  et  al  (33) 
suggest that a given clone of antibody-forming cells can also be stimulated by 
structures  as dissimilar as DNP and menadione.  However, it is not clear why 
in primary  immune  responses it is so difficult  to  detect cross-stimulation  by 
such similar cross-reacting ligands  as DNP and TNP  (34). The contributions 
of cross-stimulation  and multispecificity to the triggering of antibody-forming 
cells remain to be established. 
SUMMARY 
To explore the possibility  that the affinity  of some myeloma proteins for 
2,4-dinitrophenyl (DNP)  ligands is the consequence of a "strange" (i.e., 
unexpected) cross-reaction  for more natural ligands, a variety of substances 
(primarily derivatives  of purines, pyrimidines, naphthaquinone) were tested 
for ability  to block the binding of [~H]-e-DNP-L-lysine  by protein 315,  an IgA 
mouse myeloma protein  with high affinity  for DNP  ligands.  The most impres- 
sive  inhibiting  activity  was observed with 2-methyl-l,  4-napthaquinone (mena- 
dione,  vitamin Ka).  The affinity  (intrinsic  association  constant) of protein  315 
for  menadione was 5 X  10  s  L/M  (at  4°C). Because the same affinity  was meas- 
ured in direct-binding  assays  (e.g.,  equilibrium dialysis)  and in an indirect  one 
based on the assumption of competitive binding with DNP-lysine, it is likely 
that menadione and DNP  bind at overlapping sites  in the protein's  combining 
region. This conclusion is supported by molecular models which reveal  some 
common structural  features  in these  ligands.  Hence it is not surprising  that 
antinitrophenyl antibody preparations,  raised  by conventional immunization 
procedures (anti-2,4-DNP; anti-2,6-DNP; anti-2,4,6-TNP) also  bind mena- 
dione with considerable  affinity.  As with DNP  ligands,  when menadione binds 
to protein 315 or to conventional antinitrophenyl antibodies,  some of the 
protein's  tryptophan fluorescence  is quenched, there  is  a change in the ligand's 700  CROSS-REACTIONS  OF  VITAMIN  K3  AND  DNP 
absorption spectrum (hypochromia and/or red shift), and the binding is tem- 
perature-dependent  (exothermal). 
Note Added in Proof.--Additional  evidence in support of the idea that DNP and 
vitamin Ka are bound at overlapping sites on protein  315  is provided by a  recent 
"paired labeling" experiment in which  the  protein was iodinated with  12~I and  mI 
in presence and absence of  various ligands:  ~-DNP-lysine and  menadione blocked 
to the same extent the iodination of what appears to be  the  same tyrosine residue 
of protein 315's heavy chain  (O.  A.  Roholt,  B-K.  Seon,  A.  L.  Grossberg,  and  D. 
Pressman. Transplant. Proc. In press). 
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